Cite

HARVARD Citation

    Figlin, R. (n.d.). Personalized immunotherapy (AGS-003) when combined with sunitinib for the treatment of metastatic renal cell carcinoma. Expert opinion on biological therapy. pp. 1241-1248. [Online]. 
  
Back to record